For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it

Sponsorship complete. Dine on...

Nutrition, wellness, weight loss, and calmer healthy living.

Stanford Researchers Identify BRP, a Natural Appetite Suppressant with Fewer Side Effects

Jul 24, 2026
Stanford Researchers Identify BRP, a Natural Appetite Suppressant with Fewer Side Effects

Stanford Medicine researchers have identified a naturally occurring molecule called BRP that may suppress appetite and reduce body weight in a manner similar to semaglutide, the active ingredient in the weight-loss drug Ozempic. In studies conducted on animals, BRP demonstrated the ability to avoid several side effects commonly associated with semaglutide, including nausea, constipation, and significant muscle loss. This discovery could represent a significant advancement in the quest for effective appetite control and weight management solutions.

BRP operates through a different metabolic pathway and activates a distinct group of neurons in the brain, specifically targeting the hypothalamus. This small region of the brain plays a crucial role in regulating hunger, body temperature, hormone activity, and energy usage. By acting primarily within the hypothalamus, BRP may influence appetite without producing the widespread effects seen with semaglutide, which also impacts the gut, pancreas, and other tissues.

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it

Sponsorship complete. Dine on...

Assistant Professor of Pathology Katrin Svensson, PhD, who is a senior author of the research published on March 5 in Nature, has co-founded a company that plans to initiate clinical trials of BRP in humans shortly. The research team utilized artificial intelligence to aid in their discovery, allowing them to sift through proteins in a group known as prohormones. These prohormones are inactive precursors that require enzymatic processing to produce biologically active peptides. The challenge lies in identifying the few biologically significant peptides among numerous ordinary fragments that arise during protein processing.

The researchers focused on an enzyme called prohormone convertase 1/3, which has previously been linked to obesity in humans. This enzyme is responsible for cleaving prohormones at specific amino acid sequences, producing various peptides that may influence energy balance and appetite. By employing a computer algorithm named Peptide Predictor, the team searched through human protein-coding genes to identify potential peptides that could stimulate appetite regulation.

From their analysis, the researchers estimated that prohormone convertase 1/3 could generate 2,683 distinct peptides from a selected group of prohormones. Among these, they identified 100 peptides, including GLP-1, known for its role in hunger regulation and blood sugar control. Testing revealed that GLP-1 significantly activated neuronal cells, while a smaller peptide, BRP, produced an even more pronounced response, increasing neuronal activity tenfold compared to untreated cells.

In subsequent tests on lean mice and minipigs, BRP injections before feeding resulted in a reduction of food intake by as much as 50%. Additionally, when administered daily to obese mice over 14 days, BRP led to an average weight loss of 3 grams, primarily from body fat, while control mice gained weight. Treated mice also exhibited improved glucose and insulin tolerance, indicating better regulation of blood sugar levels.

Notably, behavioral assessments showed no significant differences between treated and untreated animals in terms of movement, water consumption, or anxiety-like behavior. The absence of gastrointestinal side effects, such as constipation, further distinguishes BRP from existing weight-loss treatments. The researchers are now focused on identifying the cell-surface receptors that interact with BRP and mapping the subsequent biological pathways activated by this peptide. They are also exploring methods to prolong the peptide's effects in the body, which is crucial for practical application in humans.

Svensson expressed optimism about the potential of BRP, stating, "The lack of effective drugs to treat obesity in humans has been a problem for decades. Nothing we've tested before has compared to semaglutide's ability to decrease appetite and body weight. We are very eager to learn if it is safe and effective in humans." The study involved collaboration with researchers from the University of California, Berkeley, the University of Minnesota, and the University of British Columbia, and was funded by several grants, including those from the National Institutes of Health.

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it
Vegetable Prep & Salad Spinners
Taste it

Sponsorship complete. Dine on...

For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it
Kitchen Scales

Kitchen scales for recipes that deserve more precision than 'that looks about right.'

Taste it
Meal Prep Containers

Give tomorrow's lunch a proper home. Containers for meals worth looking forward to.

Taste it
Vegetable Prep & Salad Spinners

Salad spinners and vegetable-prep tools for everyday salads, bowls, and side dishes. A little less kitchen setup, a little more time to enjoy the meal.

Taste it
Blenders & Smoothie Tools

Blenders for fruit, yogurt, soups, and the combinations you actually enjoy. Everyday kitchen tools, not a promise in a glass.

Taste it
Sheet Pans & Roasting Essentials

Sheet pans and roasting racks for vegetables and simple oven meals. Useful equipment for dinner without an elaborate production.

Taste it

Sponsorship complete. Dine on...

Across our publications

In Other News

Latest stories from other publications.

Explore all publications (opens in a new tab)